Wightman F - Search Results

1

Rasmussen TA, Anderson JL, Wightman F, Lewin SR. Rasmussen TA, et al. Among authors: wightman f. Curr Opin HIV AIDS. 2017 Jan;12(1):96-104. doi: 10.1097/COH.0000000000000328. Curr Opin HIV AIDS. 2017. PMID: 27607592 Free PMC article. Review.

2

Altering cell death pathways as an approach to cure HIV infection.

Badley AD, Sainski A, Wightman F, Lewin SR. Badley AD, et al. Among authors: wightman f. Cell Death Dis. 2013 Jul 11;4(7):e718. doi: 10.1038/cddis.2013.248. Cell Death Dis. 2013. PMID: 23846220 Free PMC article. Review.

3

HDAC inhibitors in HIV.

Wightman F, Ellenberg P, Churchill M, Lewin SR. Wightman F, et al. Immunol Cell Biol. 2012 Jan;90(1):47-54. doi: 10.1038/icb.2011.95. Epub 2011 Nov 15. Immunol Cell Biol. 2012. PMID: 22083528 Review.

4

HIV reservoirs and strategies for eradication.

Smith MZ, Wightman F, Lewin SR. Smith MZ, et al. Among authors: wightman f. Curr HIV/AIDS Rep. 2012 Mar;9(1):5-15. doi: 10.1007/s11904-011-0108-2. Curr HIV/AIDS Rep. 2012. PMID: 22249405 Review.

5

Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation.

Rasmussen TA, Schmeltz Søgaard O, Brinkmann C, Wightman F, Lewin SR, Melchjorsen J, Dinarello C, Østergaard L, Tolstrup M. Rasmussen TA, et al. Among authors: wightman f. Hum Vaccin Immunother. 2013 May;9(5):993-1001. doi: 10.4161/hv.23800. Epub 2013 Jan 31. Hum Vaccin Immunother. 2013. PMID: 23370291 Free PMC article.

6

Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+ T-Cells In Vitro.

Anderson JL, Mota TM, Evans VA, Kumar N, Rezaei SD, Cheong K, Solomon A, Wightman F, Cameron PU, Lewin SR. Anderson JL, et al. Among authors: wightman f. PLoS One. 2016 Jul 6;11(7):e0158778. doi: 10.1371/journal.pone.0158778. eCollection 2016. PLoS One. 2016. PMID: 27383184 Free PMC article.

7

No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapy.

Mota TM, Rasmussen TA, Rhodes A, Tennakoon S, Dantanarayana A, Wightman F, Hagenauer M, Roney J, Spelman T, Purcell DFJ, McMahon J, Hoy JF, Prince HM, Elliott JH, Lewin SR. Mota TM, et al. Among authors: wightman f. AIDS. 2017 May 15;31(8):1137-1141. doi: 10.1097/QAD.0000000000001442. AIDS. 2017. PMID: 28301423 Free PMC article.

8

Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV/hepatitis B virus-co-infected patient.

Gouskos T, Wightman F, Chang J, Earnest-Silveira L, Sasadeusz J, Lewin SR, Torresi J. Gouskos T, et al. Among authors: wightman f. AIDS. 2004 Aug 20;18(12):1734-7. doi: 10.1097/01.aids.0000131384.53350.59. AIDS. 2004. PMID: 15280788

9

Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.

Chang JJ, Wightman F, Bartholomeusz A, Ayres A, Kent SJ, Sasadeusz J, Lewin SR. Chang JJ, et al. Among authors: wightman f. J Virol. 2005 Mar;79(5):3038-51. doi: 10.1128/JVI.79.5.3038-3051.2005. J Virol. 2005. PMID: 15709024 Free PMC article.

10

Enhanced replicative capacity and pathogenicity of HIV-1 isolated from individuals infected with drug-resistant virus and declining CD4+ T-cell counts.

Solomon A, Lane N, Wightman F, Gorry PR, Lewin SR. Solomon A, et al. Among authors: wightman f. J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):140-8. doi: 10.1097/01.qai.0000173460.75322.93. J Acquir Immune Defic Syndr. 2005. PMID: 16186730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

94 results

Search Page